Lumos Pharma Corp - LUMO Quarterly EPS earnings growth

Lumos Therapeutics - graphic logo of issuer LUMO

Lumos Pharma, Inc. (LUMO) develops metabolism-correcting agents, creating a convenient injection-free pediatric treatment system. The percentage change in quarterly EPS demonstrates the company's market sensitivity, with the latest parameter standing at 13.90. Business stability is supported by outsourcing production to US plants and analyzing LUM-201 test results to identify strategic partners.

Lumos Pharma (LUMO) - Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 12/21/2024

Financial and market metric breakdowns for Lumos Pharma, Inc. (LUMO)

- share price and consensus valuation forecast:
Analysis of all company metrics:Lumos Pharma, Inc.
Manufactured product of Lumos Therapeutics

This indicator measures the percentage change in net earnings per share per quarter, allowing for an assessment of real capital generation rates relative to previous periods. Analyzing changes in quarterly EPS dynamics serves as a stress-testing tool, revealing the critical cash burn of Lumos Pharma, Inc. (LUMO) due to high R&D costs amid a deficit of commercial revenues.

Competitors of Lumos Pharma, Inc. (LUMO)

ASND (Ascendis Pharma) - Year-over-year net earnings per share growth for the last 12 months|MDGL: Year-over-year earnings per share growth rate for the last twelve months|CORT (Corcept Therapeutics Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rhythm Pharmaceuticals|Quarterly EPS earnings growth AKRO|Year-over-year earnings per share growth for the last twelve months MTSR (Metsera, Inc.)|Year-over-year earnings per share growth for the last twelve months moonlaketx.com MLTX|Crinetics Corp (CRNX) - Earnings per share growth in annualized terms for the last twelve months|NAMS - Year-over-year earnings per share growth for the last twelve months|SLNO: Year-over-year earnings per share growth for the last twelve months|FOLD: Quarterly EPS earnings growth|ETNB - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Agios Corp|Structure Corp (GPCR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months mimedx.com (MDXG)|Year-over-year net earnings per share growth for the last 12 months rezolutebio.com RZLT|Year-over-year earnings per share growth for the last twelve months Lexicon Pharmaceuticals, Inc. LXRX|MBX Bio - Year-over-year earnings per share growth for the last twelve months|ALT: Year-over-year net earnings per share growth for the last 12 months|AARD - Quarterly EPS earnings growth|SGMT: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months BioAge Labs, Inc. (BIOA)|Year-over-year earnings per share growth for the last twelve months Biomea Fusion Inc|Year-over-year earnings per share growth for the last 12 months QNCX (Quince Therapeutics)|Year-over-year net earnings per share growth for the last 12 months GUTS (Fractyl Health)|Year-over-year earnings per share growth rate for the last twelve months VTVT|Agape ATP Corporation - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PLUR|Synlogic Inc. - Quarterly EPS earnings growth|LPCN (Lipocine) - Year-over-year earnings per share growth for the last 12 months|MTNB (Matinas BioPharma Holdings Inc.) - Year-over-year net earnings per share growth for the last 12 months|SPRB (Spruce Biosciences, Inc.) - Year-over-year earnings per share growth for the last twelve months|GLTO (galecto.com) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months carmellrx.com (CTCX)|Quarterly EPS earnings growth ONVO|Year-over-year net earnings per share growth for the last 12 months Radius Health RDUS